| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |